Substance Withdrawal Syndrome

"Substance Withdrawal Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Descriptor ID	D013375
MeSH Number(s)	C25.775.835 F03.900.825
Concept/Terms	Substance Withdrawal Syndrome Substance Withdrawal Syndrome Substance Withdrawal Syndromes Syndrome, Substance Withdrawal Syndromes, Substance Withdrawal Withdrawal Syndrome, Substance Withdrawal Syndromes, Substance Withdrawal Symptoms Withdrawal Symptoms Symptom, Withdrawal Symptoms, Withdrawal Withdrawal Symptom Drug Withdrawal Symptoms Drug Withdrawal Symptoms Drug Withdrawal Symptom Symptom, Drug Withdrawal Symptoms, Drug Withdrawal Withdrawal Symptom, Drug Withdrawal Symptoms, Drug

Below are MeSH descriptors whose meaning is more general than "Substance Withdrawal Syndrome".

Diseases [C]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Substance Withdrawal Syndrome [C25.775.835]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Substance Withdrawal Syndrome [F03.900.825]

Below are MeSH descriptors whose meaning is related to "Substance Withdrawal Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Substance Withdrawal Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Substance Withdrawal Syndrome" by people in this website by year, and whether "Substance Withdrawal Syndrome" was a major or minor topic of these publications.

Bar chart showing 96 publications over 28 distinct years, with a maximum of 7 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	5	1	6
1998	2	0	2
1999	1	1	2
2001	2	0	2
2002	2	0	2
2003	1	1	2
2005	5	1	6
2006	2	0	2
2007	4	0	4
2008	3	4	7
2009	2	2	4
2010	2	1	3
2011	3	1	4
2012	1	3	4
2013	2	0	2
2014	2	1	3
2015	2	2	4
2016	5	1	6
2017	0	2	2
2018	3	0	3
2019	0	2	2
2020	5	1	6
2021	3	0	3
2022	1	0	1
2023	3	0	3
2024	5	1	6
2025	4	0	4

Below are the most recent publications written about "Substance Withdrawal Syndrome" by people in Profiles.

Ostrowski SJ, Adkins A, Goldfarb D, Kukowski M, Stratton D, Barton DJ, Pizon AF. Transdermal buprenorphine patch-facilitated induction of sublingual buprenorphine in hospitalized patients receiving full agonist opioids: a retrospective cohort study. Clin Toxicol (Phila). 2025 Nov; 63(11):897-905.

View in: PubMed
Erfle BA, Steel TL, Law AC, Kaufman DA, Hills-Dunlap K, Afshar M, Walkey AJ, Austad KE, Drainoni ML, Bosch NA. Pharmacological Interventions for Alcohol Withdrawal Syndrome Among Hospitalized Adults: A Multicenter Cohort Study. J Gen Intern Med. 2026 03; 41(4):1058-1068.

View in: PubMed
Lodi S, Yan S, Bovell-Ammon B, Christine PJ, Hsu HE, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data. Addiction. 2025 Aug; 120(8):1634-1645.

View in: PubMed
Williams BR, Gamble MC, Singh N, Bryant CD, Logan BA, Logan RW. Sleep and circadian rhythm activity alterations during adolescence in a mouse model of neonatal fentanyl withdrawal syndrome. Neuroscience. 2025 Mar 17; 569:85-91.

View in: PubMed
Soares WE, Schoenfeld E, Friedmann PD. Precipitated Withdrawal in the Era of Street Fentanyl-The Important Thing Is to Not Stop Questioning. JAMA Netw Open. 2024 09 03; 7(9):e2435857.

View in: PubMed
Grande LA, Hutch T, Jack K, Mironov W, Iwuoha J, Muy-Rivera M, Grillo J, Martin SA, Herring A. Ketamine-assisted buprenorphine initiation: a pilot case series. Addict Sci Clin Pract. 2024 08 29; 19(1):60.

View in: PubMed
Smith ACW, Ghoshal S, Centanni SW, Heyer MP, Corona A, Wills L, Andraka E, Lei Y, O'Connor RM, Caligiuri SPB, Khan S, Beaumont K, Sebra RP, Kieffer BL, Winder DG, Ishikawa M, Kenny PJ. A master regulator of opioid reward in the ventral prefrontal cortex. Science. 2024 06 07; 384(6700):eadn0886.

View in: PubMed
Gamble MC, Miracle S, Williams BR, Logan RW. Endocannabinoid agonist 2-arachidonoylglycerol differentially alters diurnal activity and sleep during fentanyl withdrawal in male and female mice. Pharmacol Biochem Behav. 2024 07; 240:173791.

View in: PubMed
Long B, Keim SM, Gottlieb M, Rathlev N. Is Phenobarbital an Effective Treatment for Alcohol Withdrawal Syndrome? J Emerg Med. 2024 Nov; 67(5):e494-e503.

View in: PubMed
Chionatos RA, Lerner DP, Burns JD, Ramineni A. Alcohol-related posterior reversible encephalopathy syndrome: a case report of a patient managed with a benzodiazepine-sparing regimen for alcohol withdrawal. Neurocase. 2023 06; 29(3):75-80.

View in: PubMed

People

Explore

Similar Concepts

Top Journals